LGND stock news
This page provides real-time market news, earnings updates, and company announcements related to Ligand Pharmaceuticals Incorporated (LGND).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-16 17:10 EST
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
Finviz2026-03-10 11:07:14
Ligand initiated with a Buy at BofA
Finviz2026-03-11 10:16:00
Here Are Wednesday's Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More
Finviz2026-03-11 11:48:58
Bofa Global Research announced that it has initiated coverage of Ligand Pharmaceuticals Inc. for the first time, assigning it a "Buy" rating.
老虎证券2026-03-11 13:50:39
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Finviz2026-03-12 12:21:47
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
Finviz2026-03-16 11:03:46
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Finviz2026-03-16 20:12:46
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Finviz2026-03-16 20:33:54
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
Finviz2026-03-17 20:36:49
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
Finviz2026-03-18 21:03:57
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Finviz2026-03-23 20:36:10
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
Finviz2026-03-25 11:36:46
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Finviz2026-03-26 11:03:09
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
Finviz2026-03-26 13:18:55
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:33:47
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
Finviz2026-03-30 13:09:49
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
Finviz2026-03-31 11:03:10
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
Finviz2026-04-01 12:51:48
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 12:33:52
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
Finviz2026-04-06 13:12:04
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Finviz2026-04-09 13:09:53
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-10 20:33:07
Pelthos Therapeutics Announces CFO Transition
Finviz2026-04-10 21:03:49
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI (sparsentan) in FSGS
Finviz2026-04-14 11:03:55
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Finviz2026-03-12 12:21:47
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
Finviz2026-03-16 11:03:46
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Finviz2026-03-16 20:12:46
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Finviz2026-03-16 20:33:54
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
Finviz2026-03-17 20:36:49
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
Finviz2026-03-18 21:03:57
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Finviz2026-03-23 20:36:10
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
Finviz2026-03-25 11:36:46
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Finviz2026-03-26 11:03:09
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
Finviz2026-03-26 13:18:55
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:33:47
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
Finviz2026-03-30 13:09:49
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
Finviz2026-03-31 11:03:10
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
Finviz2026-04-01 12:51:48
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 12:33:52
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
Finviz2026-04-06 13:12:04
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Finviz2026-04-09 13:09:53
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-10 20:33:07
Pelthos Therapeutics Announces CFO Transition
Finviz2026-04-10 21:03:49
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI (sparsentan) in FSGS
Finviz2026-04-14 11:03:55
LGND stock chart
LGND stock detailsLGND stock price change
On the last trading day, LGND stock closed at 232.34 USD, with a price change of 8.85% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more